A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or Obese

NCT03574584 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Metabolism and Nutrition Disorders
Overweight or Obesity

Interventions

DRUG: NNC0165-1562
DRUG: Semaglutide
DRUG: Placebo (NNC0165-1562)

Sponsor

Novo Nordisk A/S